Receptor Tyrosine Kinase Inhibitors [MoA] - N0000020000
Pharmacologic Class Information
Pharmacologic Code | N0000020000 |
Pharmacologic Name | Receptor Tyrosine Kinase Inhibitors |
Pharmacologic Uses |
|
Pharmacologic Concept | Mechanisms of Action - [MoA] |
Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Receptor Tyrosine Kinase Inhibitors
The table contains 15 products whose active ingredient are classified under the same pharmacologic class Receptor Tyrosine Kinase Inhibitors [MoA].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0069-0145 | Inlyta | Non-Proprietary Name: Axitinib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
0069-0151 | Inlyta | Non-Proprietary Name: Axitinib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
0069-0251 | Xalkori | Non-Proprietary Name: Crizotinib | Capsule, Coated Pellets | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
0069-0507 | Xalkori | Non-Proprietary Name: Crizotinib | Capsule, Coated Pellets | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
0069-1500 | Xalkori | Non-Proprietary Name: Crizotinib | Capsule, Coated Pellets | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
0069-8140 | Xalkori | Non-Proprietary Name: Crizotinib | Capsule | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
0069-8141 | Xalkori | Non-Proprietary Name: Crizotinib | Capsule | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
0078-0698 | Rydapt | Non-Proprietary Name: Rydapt | Capsule, Liquid Filled | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | |
62856-704 | Lenvima | Non-Proprietary Name: Lenvatinib | Capsule | Oral | Eisai Inc. | ACTIVE | |
62856-708 | Lenvima | Non-Proprietary Name: Lenvatinib | Capsule | Oral | Eisai Inc. | ACTIVE | |
62856-710 | Lenvima | Non-Proprietary Name: Lenvatinib | Capsule | Oral | Eisai Inc. | ACTIVE | |
62856-712 | Lenvima | Non-Proprietary Name: Lenvatinib | Capsule | Oral | Eisai Inc. | ACTIVE | |
62856-720 | Lenvima | Non-Proprietary Name: Lenvatinib | Capsule | Oral | Eisai Inc. | ACTIVE | |
63539-026 | Inlyta | Non-Proprietary Name: Axitinib | Tablet, Film Coated | Oral | U.s. Pharmaceuticals | ACTIVE | |
63539-044 | Inlyta | Non-Proprietary Name: Axitinib | Tablet, Film Coated | Oral | U.s. Pharmaceuticals | ACTIVE |